Table 1.
Tumor characteristics and mean platinum uptake, by dose group
| Drug | Dose, mg/kg | No. tumors analyzed | Median no. tumors per mouse(range) | Median tumor length in mm(range) | Median tumor width in mm(range) | Mean† tumor volume in mm3(95% CI)* | Mean† tumor wet weight in mg(95% CI)* | Mean† tumor platinum in ng Pt/mg tumor weight(95% CI)* |
|---|---|---|---|---|---|---|---|---|
| DDP | 10 | 129a | 19.0 (2–23) | 4 (2–11) | 3 (2–10) | 16.2 (11.5–22.8) | 15.1 (12.3–18.6) | 1.92 (0.85, 4.32) |
| CBDCA | 12.4 | 384b | 34.0 (1–60) | 4 (2–22) | 3 (1–12) | 14.0 (10.8–18.1) | 16.6 (14.3–19.3) | 0.57 (0.29, 1.11) |
| CBDCA | 85 | 236c | 18.5 (6–45) | 4 (1–20) | 2 (1–9) | 10.3 (7.8–13.5) | 16.2 (13.8–19.0) | 2.47 (1.28, 4.79) |
n=9 mice,
n=12 mice,
n=12 mice,
=p>0.05, DDP=cisplatin, CBDCA=carboplatin, Pt=platinum.
Means and standard errors were calculated from log-transformed data using a random intercept model; values reported here are exponentiated model estimates and so estimate the geometric mean.